Pasithea Therapeutics (KTTA) Interest Coverage Ratio (2021 - 2026)
Pasithea Therapeutics (KTTA) posted Interest Coverage Ratio of 7.74 for Q1 2026, up 94.13% sequentially from 131.85 in Q4 2025, and down 165.02% YoY from 11.9 in Q1 2025.
Pasithea Therapeutics (KTTA) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Pasithea Therapeutics has reported Interest Coverage Ratio for 6 years, with the latest figure at 7.74 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 165.02% year-over-year to 7.74 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 35.0 (down 217.56% YoY) and the FY2025 annual result came in at 0.02, up 99.99% from the prior year.
- Interest Coverage Ratio advanced to 7.74 in Q1 2026 per KTTA's latest filing, from 131.85 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 1.59 in Q3 2024 and troughed at 323.62 in Q4 2022.
- A 5-year average of 42.38 and a median of 6.06 in 2023 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio slumped 15301.49% in 2022, then soared 73.57% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 323.62 in 2022, then jumped by 98.14% to 6.01 in 2023, then surged by 73.57% to 1.59 in 2024, then plunged by 8195.84% to 131.85 in 2025, then surged by 94.13% to 7.74 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 7.74, 131.85, and 4.94 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Pasithea Therapeutics | 16.97 Mn | 16.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.74 |
| Dec 31, 2025 | -131.85 |
| Sep 30, 2025 | -4.94 |
| Jun 30, 2025 | -6.05 |
| Mar 31, 2025 | -2.92 |
| Sep 30, 2024 | -1.59 |
| Jun 30, 2024 | -6.26 |
| Mar 31, 2024 | -6.41 |
| Sep 30, 2023 | -6.01 |
| Jun 30, 2023 | -6.08 |
| Mar 31, 2023 | -5.10 |
| Dec 31, 2022 | -323.62 |
| Dec 31, 2021 | -2.10 |